World Library  
Flag as Inappropriate
Email this Article

Prostacyclin synthase

Article Id: WHEBN0009922273
Reproduction Date:

Title: Prostacyclin synthase  
Author: World Heritage Encyclopedia
Language: English
Subject: Prostanoid, Thromboxane-A synthase, Prostacyclin, Diacylglycerol lipase, 5-lipoxygenase-activating protein
Publisher: World Heritage Encyclopedia

Prostacyclin synthase

prostaglandin-I synthase
Cartoon diagram of human prostacyclin synthase. Heme group visible at center. From ​
EC number
CAS number 65802-86-0
IntEnz IntEnz view
ExPASy NiceZyme view
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO
Prostaglandin I2 (prostacyclin) synthase
PDB rendering based on 2iag.
Available structures
PDB Ortholog search: PDBe, RCSB
Symbols  ; CYP8; CYP8A1; PGIS; PTGI
External IDs IUPHAR: ChEMBL: GeneCards:
EC number
Species Human Mouse
RefSeq (mRNA)
RefSeq (protein)
Location (UCSC)
PubMed search

Prostaglandin-I synthase (EC also known as prostaglandin I2 (prostacyclin) synthase (PTGIS) or CYP8A1 is an enzyme involved in prostanoid biosynthesis that in humans is encoded by the PTGIS gene.[1] This enzyme belongs to the family of cytochrome P450 isomerases.


  • Function 1
  • Nomenclature 2
  • Pathways 3
  • See also 4
  • References 5
  • Further reading 6
  • External links 7


This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostaglandin H2 to prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation. An imbalance of prostacyclin and its physiological antagonist thromboxane A2 contribute to the development of myocardial infarction, stroke, and atherosclerosis.[2]

Unlike most P450 enzymes, PGIS does not require molecular oxygen (O2). Instead it uses its heme cofactor to catalyze the isomerization of prostaglandin H2 to prostacyclin. Prostaglandin H2 is produced by cyclooxygenase in the first committed step of prostaglandin biosynthesis.


The systematic name of this enzyme class is (5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate 6-isomerase. Other names in common use include prostacyclin synthase, prostacyclin synthetase, prostagladin I2 synthetase, PGI2 synthase, PGIS, PTGIS, and PGI2 synthetase.


Thromboxane synthesis
Eicosanoid synthesis.

See also


  1. ^ Yokoyama C, Yabuki T, Inoue H, Tone Y, Hara S, Hatae T, Nagata M, Takahashi EI, Tanabe T (September 1996). "Human gene encoding prostacyclin synthase (PTGIS): genomic organization, chromosomal localization, and promoter activity". Genomics 36 (2): 296–304.  
  2. ^ "Entrez Gene: PTGIS". 

Further reading

  • DeWitt DL, Smith WL (1983). "Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein". J. Biol. Chem. 258 (5): 3285–93.  
  • Ullrich V, Castle L, Weber P (1981). "Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase". Biochem. Pharmacol. 30 (14): 2033–6.  
  • Xie X, Ma YT, Fu ZY, et al. (2008). "[Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China]". Zhonghua Liu Xing Bing Xue Za Zhi 29 (6): 598–603.  
  • Yoshida T, Kato K, Yokoi K, et al. (2009). "Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.". Int. J. Mol. Med. 24 (2): 233–46.  
  • Palmieri RT, Wilson MA, Iversen ES, et al. (2008). "Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.". Cancer Epidemiol. Biomarkers Prev. 17 (12): 3567–72.  
  • Mavaddat N, Dunning AM, Ponder BA, et al. (2009). "Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.". Cancer Epidemiol. Biomarkers Prev. 18 (1): 255–9.  
  • Xie X, Ma YT, Fu ZY, et al. (2009). "[Association of GLu461ALa polymorphism of prostacyclin synthase gene with myocardial infarction in Uigur population]". Zhonghua Yu Fang Yi Xue Za Zhi 43 (3): 237–41.  
  • Yoshida T, Kato K, Fujimaki T, et al. (2009). "Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.". Genomics 93 (3): 221–6.  
  • Dagle JM, Lepp NT, Cooper ME, et al. (2009). "Determination of genetic predisposition to patent ductus arteriosus in preterm infants.". Pediatrics 123 (4): 1116–23.  
  • Xie X, Ma Y, Fu Z, et al. (2008). "[Association of polymorphism of the prostacyclin synthase gene with myocardial infarction in Uigur population of Xinjiang]". Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25 (6): 708–11.  
  • Nelson DR, Zeldin DC, Hoffman SM, et al. (2004). "Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.". Pharmacogenetics 14 (1): 1–18.  
  • Barbalić M, Narancić NS, Skarić-Jurić T; et al. (2009). "A quantitative trait locus for SBP maps near KCNB1 and PTGIS in a population isolate.". Am. J. Hypertens. 22 (6): 663–8.  
  • Xie X, Ma YT, Fu ZY, et al. (2009). "Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction.". Clin. Chem. Lab. Med. 47 (3): 347–52.  
  • Abraham JE, Harrington P, Driver KE, et al. (2009). "Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.". Clin. Cancer Res. 15 (6): 2181–91.  
  • Ruan KH, Wu J, Cervantes V (2008). "Characterization of the substrate mimic bound to engineered prostacyclin synthase in solution using high-resolution NMR spectroscopy and mutagenesis: implication of the molecular mechanism in biosynthesis of prostacyclin.". Biochemistry 47 (2): 680–8.  
  • Hashimoto K, Ishibashi K, Gebretsadik T, et al. (2008). "Functional polymorphism of the promoter region of the prostacyclin synthase gene and severity of RSV infection in hospitalized children.". J. Med. Virol. 80 (11): 2015–22.  
  • Xiang Xie , Ma YT, Fu ZY; et al. (2009). "Haplotype analysis of the CYP8A1 gene associated with myocardial infarction.". Clin. Appl. Thromb. Hemost. 15 (5): 574–80.  
  • Lemaitre RN, Rice K, Marciante K, et al. (2009). "Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.". Atherosclerosis 204 (2): e58–63.  
  • Ito T, Okada T, Mimuro J, et al. (2007). "Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats.". Hypertension 50 (3): 531–6.  
  • Ma YT, Xie X, Fu ZY, et al. (2009). "[Haplotypes analysis of the prostacyclin synthase gene and myocardial infarction in Uigur population]". Zhonghua Xin Xue Guan Bing Za Zhi 37 (2): 115–9.  
  • Yeh HC, Gerfen GJ, Wang JS, et al. (2009). "Characterization of the peroxidase mechanism upon reaction of prostacyclin synthase with peracetic acid. Identification of a tyrosyl radical intermediate.". Biochemistry 48 (5): 917–28.  
  • Young RP, Hopkins RJ, Hay BA, et al. (2009). "A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers.". Postgrad Med J 85 (1008): 515–24.  

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.